Skip to main content
Clinical Trials/JPRN-jRCT2092220032
JPRN-jRCT2092220032
Completed
Phase 3

A Clinical Study Evaluating the Safety and Efficacy of BS054 Combined with Coil Embolization as a Treatment of Unruptured Wide Neck Intracranial Aneurysm - BS054

Boston Scientific Japan K.K.0 sites20 target enrollmentSeptember 9, 2009

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Boston Scientific Japan K.K.
Enrollment
20
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 9, 2009
End Date
May 31, 2011
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\)Unruptured wide neck intracranial aneurysm
  • 2\)The parent artery diameter within the range of 2\.0 to 4\.5 mm.
  • 3\)The target intracranial aneurysm is difficult to be treated by surgery and coil embolization with the use of embolization coils alone.

Exclusion Criteria

  • 1\)The target intracranial aneurysm has a history of rupture.
  • 2\)Stent implantation in the neck or cranium within 4 weeks before the study procedure.
  • 3\)Two or more untreated intracranial aneurysms with the maximum diameters of \>\= 10 mm.
  • 4\)The access of the Stent to the target intracranial aneurysm is considered impossible anatomically or procedurally by angiography, or the access to the intracranial aneurysm is impossible because of severe vasospasm refractory to medications.
  • 5\)The patient has hemorrhagic diathesis.
  • 6\)Antiplatelet/anticoagulation therapy is contraindicated.
  • 7\)The patient has a complication of a disease condition causing cardiogenic cerebral infarction.
  • 8\)Renal failure (serum creatinine \>\= 2\.0 mg/dL).

Outcomes

Primary Outcomes

Not specified

Similar Trials